Navigation Links
Synthetic Biologics to Report Third Quarter 2013 Financial Results
Date:11/7/2013

ROCKVILLE, Md., Nov. 7, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, announced today that it intends to release its financial results for the third quarter ended September 30, 2013 on Thursday, November 14, 2013.

(Logo: http://photos.prnewswire.com/prnh/20130522/MM19465LOGO)

The Company will hold an investor conference call on Thursday, November 14, 2013, at 10:00 am EST. During the call, Jeffrey Riley, Synthetic Biologics' Chief Executive Officer, will provide a brief quarterly update of the Company's multiple sclerosis program and its anti-infective drug pipeline for infectious diseases, including its oral enzyme candidate for the prevention of C. difficile infections. C. Evan Ballantyne, Synthetic Biologics' Chief Financial Officer, will review the Company's financial results for the third quarter ended September 30, 2013.

Interested parties should call 1-877-870-4263 (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1 412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet at http://www.videonewswire.com/event.asp?id=96920. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=96920 for 30 days after the call.

About Synthetic Biologics, Inc.

Synthetic Biologics, Inc. (NYSE MKT: SYN) is a bio
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Atlantic Peptides, a Synthetic Peptide Manufacturer, Unveils Its New Website for Easier Navigation
2. Synthetic Biologics Responds to Recent CDC Report on Threat of "Super Bugs"
3. Synthetic Biologics to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
4. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
5. Synthetic Biologics to Report Second Quarter 2013 Financial Results
6. Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
7. Synthetic DNA Deemed Patentable by US Supreme Court, Gene Synthesis and Codon Optimization Provide Potential Pathway to Patentability
8. Synthetic Biologics to Present at OneMedForum New York 2013
9. New England Biolabs supports iGEM synthetic biology competition
10. Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
11. Intrexon Organizes Around New Synthetic Biology Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Robert Harman, ... Veterinary Medicine company, is proud to announce the relaunch of ... launching with a new series called “ What are Stem ... give an honest and straightforward foundation in the basics of ... educated decision on the right type of treatment when considering ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Senior ... institutions and professional associations, addressed the challenges of “Reducing ... Medical Device Industries” through strategic sourcing. Describing the partnership ... with the Supply Chain Management Institute ( SCMI) ... event on June 24 at the Kroc Institute of ...
(Date:7/10/2014)... -- Kainos Capital, a firm specializing in acquiring and managing ... acquired the Slim-Fast brand from Unilever. Unilever will retain ... transaction were not disclosed. Slim-Fast is a ... ready-to-drink shakes, powders, bars and snacks to retail customers ... the United Kingdom and Ireland.  ...
(Date:7/10/2014)... OAKS, Calif., July 10, 2014   Ceres, Inc ... and seed company, announced today financial results for the ... update on its business. Ceres reported that ... in product performance this growing season in Brazil, which ... affected the company,s sorghum evaluation areas for part of ...
Breaking Biology Technology:Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4Kainos Capital Acquires Slim-Fast From Unilever 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9
... College, MIT, Clemson and Virginia have used nanotechnology to ... of merit of p-type half-Heusler, a common bulk semiconductor ... journal Nano Letters . The dramatic increase ... material,s relative thermoelectric performance, could pave the way for ...
... RxTrials, Inc., a network of premier clinical research ... national clinical research consultant and education provider, has earned ... certification was presented by the Women,s Business Enterprise National ... visit. The nationally recognized certification from WBENC ...
... that a new market research report is available ... of In Vitro and In Vivo Diagnostic Integration ... The term in-vitro/in-vivo diagnostics (IV2D) describes the integration ... as well as new software and IT platforms. ...
Cached Biology Technology:Nanotech milling produces dramatic increase in thermoelectric performance of bulk semiconductor 2RxTrials Earns National Women-Owned Business Certification 2Reportlinker Adds The Future of In Vitro and In Vivo Diagnostic Integration 2Reportlinker Adds The Future of In Vitro and In Vivo Diagnostic Integration 3
(Date:7/11/2014)... animals often develop relationships with other group members to ... wild chacma baboons the strategy for grooming activities shows ... just published in the scientific journal Biology Letters ... baboons is not practiced without ulterior motives. To be ... the individual, while grooming another individual can provide access ...
(Date:7/11/2014)... evidence has demonstrated that transplantation of mesenchymal stem cells ... or mouse models of Alzheimer,s disease (AD) and improve ... ischemia. Few studies are reported on the therapeutic effect ... AD and on the effect on oxidative injury and ... Yan and her team, School of Life Sciences, Tsinghua ...
(Date:7/11/2014)... the proteins that let nerve cells send out electrical ... a biological tactic that may offer a new way ... and environmentally responsible way. , Their findingthat naturally ... and harmless for a closely related onesuggests that insecticides ... beneficial species like bees. A summary of the research, ...
Breaking Biology News(10 mins):Baboons groom early in the day to get benefits later 2Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3
... Mich. --- Tiny creatures at the bottom of the ... of the atmosphere,s carbon dioxide, yet research by Michigan ... to "sequester" that greenhouse gas as the climate warms. ... living in puddles, lakes and oceans. ...
... Alexandria, Va. The International Association for Dental ... Tufts,University, Boston, Massachusetts, USA, as the 2009 recipient ... presented at the IADR 87th General Session & ... 2009,Dr. Papas is the Erling Johansen Professor of ...
... developed by the UK,s National Oceanography Centre, Southampton, has ... under an Antarctic glacier. Autosub has been exploring ... Antarctic ice sheet, using sonar scanners to map the ... juts into the sea. Scientists hope to learn why ...
Cached Biology News:Mighty diatoms: Global climate feedback from microscopic algae 2Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award 2UK robot sub searches for signs of melting 60 km into an Antarctic ice shelf cavity 2UK robot sub searches for signs of melting 60 km into an Antarctic ice shelf cavity 3
... c-Jun proto-oncogene was first identified as the cellular ... Jun B and Jun D have been shown ... C-terminal regions, which are involved in dimerization and ... involved in transcriptional activation, diverge. ...
... (phospho Y1007) ( Abpromise for ... Antigen: Synthesized phosphopeptide derived from ... of tyrosine 1007 (K-E-Y P -Y-K). ... 3717 Swiss ...
Harmful, Irritant, Combustible ,DEPC...
Permeabilization Solution, 5X...
Biology Products: